- Home
- STOK vs MNTK Comparison
STOK vs MNTK Comparison
Compare STOK & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- MNTK
- Stock Information
- Founded
- STOK 2014
- MNTK 1980
- Country
- STOK United States
- MNTK United States
- Employees
- STOK N/A
- MNTK N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- MNTK Natural Gas Distribution
- Sector
- STOK Health Care
- MNTK Utilities
- Exchange
- STOK Nasdaq
- MNTK Nasdaq
- Market Cap
- STOK 721.4M
- MNTK 798.5M
- IPO Year
- STOK 2019
- MNTK 2021
- Fundamental
- Price
- STOK $12.03
- MNTK $4.12
- Analyst Decision
- STOK Strong Buy
- MNTK Hold
- Analyst Count
- STOK 7
- MNTK 2
- Target Price
- STOK $21.40
- MNTK $6.00
- AVG Volume (30 Days)
- STOK 405.8K
- MNTK 214.6K
- Earning Date
- STOK 11-05-2024
- MNTK 11-12-2024
- Dividend Yield
- STOK N/A
- MNTK N/A
- EPS Growth
- STOK N/A
- MNTK 42.11
- EPS
- STOK N/A
- MNTK 0.16
- Revenue
- STOK $16,742,999.00
- MNTK $194,849,000.00
- Revenue This Year
- STOK $91.67
- MNTK $22.46
- Revenue Next Year
- STOK $5.45
- MNTK $22.06
- P/E Ratio
- STOK N/A
- MNTK $25.47
- Revenue Growth
- STOK 81.08
- MNTK 9.63
- 52 Week Low
- STOK $3.77
- MNTK $3.38
- 52 Week High
- STOK $17.58
- MNTK $9.75
- Technical
- Relative Strength Index (RSI)
- STOK 39.51
- MNTK 29.06
- Support Level
- STOK $13.39
- MNTK $4.00
- Resistance Level
- STOK $14.72
- MNTK $5.78
- Average True Range (ATR)
- STOK 0.68
- MNTK 0.42
- MACD
- STOK 0.03
- MNTK -0.20
- Stochastic Oscillator
- STOK 7.24
- MNTK 5.88
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.